Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Curr Opin Nephrol Hypertens. 2018 Nov;27(6):445–453. doi: 10.1097/MNH.0000000000000456

Figure 4. Risk of HIV superinfection and drug resistance associated with HIV-positive organ donors.

Figure 4.

Patients on first-line ART regimens, infected with R5 tropic virus, who have potential for protease inhibitor ritonavir-sparing ART regimens, and who have higher CD4+ T-cell counts are at lower risk of causing HIV superinfection or spreading drug resistance.